Kenvue Faces Turbulence Amid Tylenol Controversy

about 1 month ago

Tom Keen with Paul Sweeney and Bloomberg\'s John Tucker

"Don\'t take Tylenol. President Trump instructing pregnant women... Kenview disputed any link between the drug and autism this week. They also warned the pregnant mothers don\'t use Tylenol when in need. They could face a dangerous choice between suffering fevers or using riskier alternatives."

The segment discusses Kenvue, the consumer brands company spun off from Johnson & Johnson, highlighting recent trading volatility with a nearly 7-7.5% drop followed by a bounce back. The commentary focuses on ongoing legal controversies related to Tylenol and alleged links to autism, suggesting potential near-term risks and investor caution.

Related Stocks